bing gao

Dr. bing gao


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2025 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
WZWenxuan Zhang
Wenxuan Zhang
BGbing gao
bing gao
YWYaping Wang
Yaping Wang
YCYuxiang Cao
Yuxiang Cao
JWJing Wang
Jing Wang
The Hepatic Steatosis Index (HSI) serves as a non-invasive indicator for assessing liver fat accumulation. Its potential association with hypertension has garnered increasing attention, as metabolic dysfunctions, including hepatic steatosis, may contribute to elevated blood pressure via mechanisms such as insulin resistance and chronic inflammation. Utilizing data from the NHANES database (2011–2018), the HSI was calculated on the basis of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and BMI.The association between HSI and hypertension was assessed by univariate analysis, weighted multivariate Logistic regression, and restricted cubic spline (RCS) models. Subgroup analyses were performed to increase the reliability of the data. This cross-sectional study analysed data from 17,501 adults (NHANES 2011–2018) to assess the association between HSI and hypertension. Of these, 9,890 (56.51%) were diagnosed with hypertension.In the unadjusted model, HSI demonstrated a statistically significant correlation with hypertension, showing an odds ratio (OR) of 1.05 (95% confidence interval: 1.04–1.06).After adjustment for potential confounders, a higher prevalence of hypertension was observed in participants in the upper HSI quartiles (Q3 and Q4), with corresponding ORs of 2.29 (95% CI: 2.29–2.63) and 4.03 (95% CI: 3.42–4.74), respectively. RCS analysis revealed a U-shaped non-linear relationship between HSI and hypertension (P < 0.001), indicating that while hypertension risk primarily escalated with increasing HSI, a modest risk elevation was also detected at lower HSI levels. This suggests that both excessive liver fat accumulation (indicated by a high HSI) and underlying metabolic disorders (such as malnutrition or sarcopenia) may contribute to hypertension risk in individuals with unexpectedly low HSI. Subgroup analyses identified significant interactions in relation to education, cancer, and diabetes mellitus (p for interaction < 0.05), whereas no significant interactions were observed in other stratifications. This study found a U-shaped relationship between the hepatic steatosis index (HSI) and the risk of hypertension. Although the HSI shows potential as a practical screening tool in primary care, further longitudinal studies are needed to establish causality and explore the complex bidirectional pathways involved. Not applicable.

28 July 2024 in Archives of Medical Science
Verified
Journal Article
Open access
PLPan Liu
Pan Liu
THTairan Hu
Tairan Hu
BGbing gao
bing gao
RXRan Xia
Ran Xia
XDXiaohua Dai
Xiaohua Dai
JWJing Wang
Jing Wang
Introduction: In China, Yanggan-Yishui granules (YGYSG) have been used to treat hypertensive renal damage (HRD) for over 20 years. Network pharmacology was used to determine whether YGYSG affects HRD via the autophagy pathway, which was verified using in vitro experiments.Material and methods: Common targets of YGYSG, HRD, and the autophagy pathway were screened using network pharmacology, and effective compounds, core targets, and signaling pathways were identified. The affinity of the compounds for the core targets was evaluated using molecular docking simulations. Angiotensin II (Ang II) was used to generate an in vitro renal podocyte model using MPC-5 cells. Morphological changes in the autophagosomes were observed using transmission electron microscopy (TEM). The expression levels of autophagy-related and pathway proteins were detected using western blotting and reverse transcription quantitative real-time PCR (PCR).Results: Network pharmacology and molecular docking analyses identified eight autophagy-related core targets and ten core components in the YGYSG treatment of HRD. These targets are mainly involved in the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling pathway and autophagy-related biological processes. In vitro experiments showed that Ang II-stimulated renal podocytes exhibited abnormal autophagy, and YGYSG protected renal podocytes from abnormal autophagy. In addition, YGYSG reversed abnormal autophagy and improved HRD by activating the PI3K/AKT/mTOR signaling pathway.Conclusions: YGYSG may regulate abnormal autophagy in renal podocytes by activating the PI3K/AKT/mTOR signaling pathway and may play a role in improving HRD.

18 July 2026 in Respiratory Medicine
Verified
Journal Article
Closed access
WZWenxuan Zhang
Wenxuan Zhang
LLLiya Li
Liya Li
SDShuting Du
Shuting Du
YWYaping Wang
Yaping Wang
YCYuxiang Cao
Yuxiang Cao
BGbing gao
bing gao

20 March 2026 in Nutrition, Metabolism and Cardiovascular Diseases
Verified
Journal Article
Open access
WZWenxuan Zhang
Wenxuan Zhang
LLLiya Li
Liya Li
YWYaping Wang
Yaping Wang
YCYuxiang Cao
Yuxiang Cao
CHChengyun Hu
Chengyun Hu
BGbing gao
bing gao
Hyperlipidemia is a well-established risk factor for cardiovascular disease (CVD) and all-cause mortality. The estimated glucose disposal rate (eGDR), a non-invasive marker of insulin resistance, has shown potential in predicting CVD outcomes. However, its association with mortality in individuals with hyperlipidemia remains unclear. This study aimed to investigate the relationship between eGDR and both all-cause and CVD-specific mortality in a hyperlipidemic population. The present study used data from the National Health and Nutrition Examination Survey (NHANES) from 2005 to 2018 to calculate the eGDR in a sample of 9283 adults diagnosed with hyperlipidaemia. Participants were stratified into eGDR quartiles (Q1-Q4). Cox regression was employed to assess mortality risks.Especially significant in subgroup analysis for patients under 60 years of age.Lower eGDR quartiles exhibited metabolic profiles that were indicative of poorer health and elevated mortality rates (all-cause: Q1 = 13.08% vs. Q4 = 3.07%; CVD: 4.06% vs. 0.48%). An increase of one unit in the eGDR was associated with a 7% reduction in all-cause mortality (HR = 0.93) and a 14% reduction in CVD mortality (HR = 0.86). In comparison with the first quarter, the fourth quarter exhibited a 40% decrease in all-cause mortality (hazard ratio [HR] = 0.60) and a 56% decrease in CVD mortality (HR = 0.44). Mediation analyses implicated eGFR(36.5%) in these associations. In patients suffering from hyperlipidaemia in the US, a decrease in eGDR has been shown to be associated with an increased risk of all-cause and cardiovascular disease mortality.

1 September 2026 in Human Fertility
Verified
Journal Article
Open access
YWYaping Wang
Yaping Wang
WZWenxuan Zhang
Wenxuan Zhang
YCYuxiang Cao
Yuxiang Cao
PGPing Gong
Ping Gong
QLQingling Li
Qingling Li
BGbing gao
bing gao
Female infertility is a major reproductive health concern worldwide and is commonly defined as the inability to achieve a clinical pregnancy after 12 months of regular unprotected sexual intercours...